Immunology News and Research

Latest Immunology News and Research

Expedeon AG launches Lightning-Link Metal Labeling Kits to support single cell analysis

Expedeon AG announced today it has introduced Lightning-Link Metal Labeling Kits for use in multiple immunoassay-based applications to support single cell analysis.

24 Jun 2019

Non-classical monocytes directly involved in regulation of immune response

Non-classical monocytes were long thought to play a purely surveillance role in the immune system. With the aid of a novel marker, Ludwig-Maximilians-Universitaet in Munich researchers have now shown that they are directly involved in the regulation of immune response

24 Jun 2019

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration for patients with an aggressive form of non-Hodgkin lymphoma.

24 Jun 2019

Elite group of immune cells plays key role in fighting tumors

Immunotherapies hold promise as a way to prompt a patient's own immune system to fight cancer cells. Yet immunotherapies only work in about 30 percent of patients-;and they can cause dangerous side effects.

24 Jun 2019

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

For decades, University Distinguished Professor of Molecular Virology X.J. Meng and his lab at the Virginia-Maryland College of Veterinary Medicine have studied hepatitis E virus (HEV), the causative agent of hepatitis E in humans.

21 Jun 2019

UVA launches Fibrosis Initiative to fight the growing cause of death

Fibrosis is often associated with many of the fatal diseases that pervade our globe, riddling organs with stiff tissue that diminishes their flexibility and leads to their failure.

21 Jun 2019

New blood test offers more precise diagnostics of ovarian cancer

The majority of women who undergo surgery for suspected ovarian cancer do not have cancer. A novel blood test developed by researchers at Uppsala University and the Sahlgrenska Academy, University of Gothenburg, in Sweden, now offers the possibility of more precise diagnostics without the need for surgery.

20 Jun 2019

Cytek Biosciences unveils advanced five-laser flow cytometer

When five lasers and more than 30 colors combine, new breakthroughs and scientific discoveries take shape.

From Cytek Biosciences 20 Jun 2019

Highlights and key takeaways from the 2019 Boston Bacterial Meeting (BBM)

Missed out on the 2019 Boston Bacterial Meeting (BBM)? Read our round-up of the key takeaways, areas of discussion, speakers and more.

19 Jun 2019

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development, it was announced today (Tuesday).

19 Jun 2019

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

Research supported by the Accelerating Medicines Partnership on Rheumatoid Arthritis and Systemic Lupus Erythematosus provides new insights into tissue damage for these autoimmune conditions.

19 Jun 2019

Researchers discover redundancies in immune cells

Researchers at ETH Zurich have discovered redundancies in the biochemical signaling pathways of immune cells. This finding has important implications for advances in cancer immunotherapy, among other areas.

18 Jun 2019

Researchers identify genetic mutation that causes fatal response to HAV infection

Researchers have identified a genetic mutation that caused an 11-year-old girl to suffer a fatal reaction to infection with the Hepatitis A virus.

18 Jun 2019

Researchers find way to reinvigorate exhausted immune cells and stop cancer

The human immune system relies on a delicate balance of finely tuned cell types that keep germs and cancerous cells in check.

18 Jun 2019

Virus employs powerful strategy to inhibit natural killer cell function

The virus responsible for chickenpox and shingles employs a powerful strategy of immune evasion, inhibiting the ability of natural killer cells to destroy infected cells and produce molecules that help control viral infection, according to a study published June 13 in the open-access journal PLOS Pathogens by Allison Abendroth of the Discipline of Infectious Diseases and Immunology in the Charles Perkins Centre at the University of Sydney, and colleagues.

From PLOS ONE 14 Jun 2019

Developing new immunotherapeutic treatments for emerging viral diseases

Emerging viral diseases is a term used to refer to diseases caused by pathogens such as the Ebola virus. Whilst vaccines can protect people against these diseases, there is an urgent need for treatment options after infection.

14 Jun 2019

Experimental antiviral drug cures mice infected with deadly tick-borne virus

Only a few cases of the newly discovered Bourbon virus have been reported, and two of them ended in death, partly because no specific treatments are available for the tick-borne illness.

14 Jun 2019

IMAS survey reveals 74% of people living with axial spondyloarthritis struggle to find a job

The European results of the International Map of Axial Spondyloarthritis reveal that people living with axial spondyloarthritis (axSpA) – a long-term inflammatory spine condition which is as prevalent as rheumatoid arthritis – face uncertainty and worry for their future, with 74% reporting difficulties finding a job due to the condition.

From Novartis 13 Jun 2019

Study shows high levels of success in most patients despite tapered glucocorticoid discontinuation

The results of a randomized controlled trial presented today at the Annual European Congress of Rheumatology demonstrate high levels of treatment success in approximately two thirds of patients despite tapered glucocorticoid discontinuation, while a small loss of disease control was observed at the total study population level.

13 Jun 2019

Human liver cell protein aids development of malaria parasite, study finds

Researchers in Japan have discovered that the Plasmodium parasites responsible for malaria rely on a human liver cell protein for their development into a form capable of infecting red blood cells and causing disease.

12 Jun 2019

Immunology News and Research

Latest Immunology News and Research

Expedeon AG launches Lightning-Link Metal Labeling Kits to support single cell analysis

Non-classical monocytes directly involved in regulation of immune response

New chemoimmunotherapy regimen for aggressive form of lymphoma gets FDA approval

Elite group of immune cells plays key role in fighting tumors

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

UVA launches Fibrosis Initiative to fight the growing cause of death

New blood test offers more precise diagnostics of ovarian cancer

Cytek Biosciences unveils advanced five-laser flow cytometer

Highlights and key takeaways from the 2019 Boston Bacterial Meeting (BBM)

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Researchers identify new clues on tissue damage in rheumatoid arthritis and lupus

Researchers discover redundancies in immune cells

Researchers identify genetic mutation that causes fatal response to HAV infection

Researchers find way to reinvigorate exhausted immune cells and stop cancer

Virus employs powerful strategy to inhibit natural killer cell function

Developing new immunotherapeutic treatments for emerging viral diseases

Experimental antiviral drug cures mice infected with deadly tick-borne virus

IMAS survey reveals 74% of people living with axial spondyloarthritis struggle to find a job

Study shows high levels of success in most patients despite tapered glucocorticoid discontinuation

Human liver cell protein aids development of malaria parasite, study finds

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics